Publications
Return to Publications Listing
Pharmaceutical Pricing and Reimbursement in Canada
Susan Neale, M.B.A.
Director of Market Access and International Research, PDCI Market Access
Arvind Mani, M.B.A., M.A.
Director of Market Access and International Policy, PDCI Market Access
This report provides an overview of the Canadian health care system and pharmaceutical market, examines drug pricing and reimbursement procedures in detail, and concludes with a brief assessment of the outlook for the Canadian pharmaceutical market.
Table of Contents
- Executive Summary
- Strategic Considerations
- Stakeholder Implications
- Introduction
- Organization and Funding of the Canadian Healthcare System
- The Canadian Pharmaceutical Market
- Recent Developments in Canada’s Drug Approval Process
- Pharmaceutical Pricing
- Pricing of Prescription Medicines
- Comprehensive Review of Excessive Price Guidelines
- Categories
- Price Tests
- Any Market Review
- Pricing Trends
- Reimbursement of Prescription Medicines
- Private Drug Plans
- Provincial and Federal Government Reimbursement
- Common Drug Review
- Common Drug Review Process
- Recent Changes
- Cancer Drugs
- Hospital Drugs
- National Pharmaceutical Strategy
- Outlook for the Canadian Pharmaceutical Market
